Featured Research

from universities, journals, and other organizations

Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery

Date:
March 7, 2013
Source:
University of New South Wales
Summary:
A medical researcher has found the third and final piece in the genetic puzzle of hemophilia B Leyden, more than 20 years after he discovered the first two pieces. The results explain how more than half of the cases of this rare blood-clotting disorder occur, could have implications for other conditions such as thrombosis and show the value of curiosity-driven research.

Professor Merlin Crossley is dean of science at University of New South Wales.
Credit: UNSW

An Australian researcher has found the third and final missing piece in the genetic puzzle of an unusual form of hemophilia, more than 20 year after he discovered the first two pieces.

Professor Merlin Crossley, of the University of New South Wales, and his international team studied the blood-clotting disorder, hemophilia B Leyden, which is unusual because symptoms improve after puberty.

The results, published in The American Journal of Human Genetics, explain how more than half of the cases of this rare, hereditary bleeding disorder occur, and could help improve understanding of other conditions such as thrombosis.

The find also demonstrates the importance of curiosity-driven research, says Crossley, who is dean of science at UNSW.

"Science is advanced by people who get caught up in puzzles that are important to them and they never forget them. Curious investigators never give up," he says.

Crossley spotted the final genetic clue two years ago, when he was on an aeroplane, marking a young researcher's PhD project. Data in the thesis reminded him of his own PhD project on hemophilia B Leyden, carried out at the University of Oxford in the late 1980s.

People with the disorder have three different categories of mutations in the gene that produces clotting factor IX, which prevents excessive bleeding. Crossley was able to work out how two of them operate, while at Oxford.

He found the two sets of mutations prevent two key proteins from attaching to the DNA, which turns the gene off as a result. Symptoms improve in young men after puberty because a different protein that responds to the hormone testosterone is able to bind to the DNA and boost the gene's production of clotting factor IX.

Crossley, and many other researchers after him, tried to find the key protein associated with the third group of mutations, which accounts for more than half the cases of the disease, but it remained elusive. "Things moved on, but I never forgot," he says.

Two decades later, on the plane, he realised the young researcher was describing a DNA-binding site for a newly discovered protein that had a very familiar ring to it. "I remembered it. It was the same sequence as for the binding site for the third group of mutations," Crossley says.

He joined forces with others at UNSW, including Dr Alister Funnell, and researchers in the UK, New Zealand and Belgium, to show the newly identified protein, ONECUT, was the missing piece in the puzzle of hemophilia B Leyden, which affects about 80 families worldwide.

The original research allowed families to be informed that their children were likely to get better after puberty.

While the new research will not alter the method of treatment for people with hemophilia B Leyden, it could lead to new approaches to regulating genes in general for experimental, or ultimately, therapeutic purposes.

"Understanding the molecular regulation of the coagulation factor IX gene may aid in the development of therapies for other blood-clotting disorders such as thrombosis," says Funnell.


Story Source:

The above story is based on materials provided by University of New South Wales. Note: Materials may be edited for content and length.


Journal Reference:

  1. AlisterP.W. Funnell, MichaelD. Wilson, Benoit Ballester, KaSin Mak, Jon Burdach, Natisha Magan, RichardC.M. Pearson, FredericP. Lemaigre, KathrynM. Stowell, DuncanT. Odom, Paul Flicek, Merlin Crossley. A CpG Mutational Hotspot in a ONECUT Binding Site Accounts for the Prevalent Variant of Hemophilia B Leyden. The American Journal of Human Genetics, 2013; 92 (3): 460 DOI: 10.1016/j.ajhg.2013.02.003

Cite This Page:

University of New South Wales. "Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery." ScienceDaily. ScienceDaily, 7 March 2013. <www.sciencedaily.com/releases/2013/03/130307123949.htm>.
University of New South Wales. (2013, March 7). Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2013/03/130307123949.htm
University of New South Wales. "Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery." ScienceDaily. www.sciencedaily.com/releases/2013/03/130307123949.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Beijing Marathon Runners Brave Hazardous Air Pollution

Beijing Marathon Runners Brave Hazardous Air Pollution

AFP (Oct. 19, 2014) Tens of thousands of runners battled thick smog at the Beijing Marathon on Sunday, with some donning masks as the levels of PM2.5 small pollutant particles soared to 16 times the maximum recommended level. Duration: 00:54 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins